1-833-256-2748
M
-
F
,
8
am -
6
pm ET
Call an Alnylam Assist® Case Manager Icon

We Are Here to Support You

Alnylam Assist™ is committed to helping you access therapy. You will work with an Alnylam Case Manager to help you have a smooth treatment experience with ONPATTRO® (patisiran) and answer questions you may have along the way.

Take a look at the summary of support below:

Alnylam Assist® - Understanding Your Benefits
Understanding Your Benefits

An Alnylam Case Manager will review your insurance coverage and answer questions about your insurance benefits for treatment with ONPATTRO.

Alnylam Assist® - Financial Assistance Options
Financial Assistancea

Alnylam offers financial assistance programs for eligible patients. After being prescribed an Alnylam product, you can talk to a Case Manager to learn if you may be eligible. Below are examples of two Alnylam Financial Assistance programs.

•I have insurance but have concerns about paying for an Alnylam product

Our Commercial Copay Program covers certain out-of-pocket costs for eligible patients with commercial insuranceb

 

•I'm uninsured, or I have insurance but do not have coverage for an Alnylam product

– Our Patient Assistance Program may be able to provide you with one of Alnylam's products at no cost if you're eligible

a  Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue any program at any time.

b  Patients with Medicare, Medicaid, or other government-sponsored insurance are not eligible for the Alnylam Assist™ Commercial Copay Program. Out-of-pocket costs for the administration of Alnylam products will not be covered for patients residing where it is prohibited by law or where otherwise restricted.

Alnylam Assist® - Disease and Treatment Education
Disease and Product Education

A Case Manager can also connect you with an Alnylam Patient Education Liaison (PEL). PELs have backgrounds in nursing and are experienced in educating family members about their disease. PELs can help you in a variety of ways, including providing disease and product education, connecting you to additional resources, and answer questions about treatment with ONPATTRO.

The purpose of Alnylam PELs is to provide education to patients, their families, and caregivers. PELs are employees of Alnylam Pharmaceuticals. They are not acting as healthcare providers and are not part of your healthcare team. PELs do not provide medical care or advice. All diagnosis and treatment decisions should be made by you and your doctor.

Introduction to Alnylam Assist™

Watch this video to learn about Alnylam Assist
Alnylam Assist® - Introduction Video
“I’m in the patients’ corner, supporting them through challenging times. That’s why I strive to go above and beyond to service those in need.”

 

Renae, Case Manager

Resources for You

Alnylam Assist® - Downloadable PDF

Download the Alnylam Assist™ Patient Brochure

Download

Alnylam Assist® - Downloadable PDF

Download the ONPATTRO Patient Brochure

Download

Who can support me with the Alnylam Assist™ program?

When you and your doctor choose to begin treatment with ONPATTRO, you will be paired with an Alnylam Case Manager in your area and have access to an Alnylam Patient Education Liaison. Learn about these roles ›

Alnylam Assist® - Questions Icon

Find answers to other

Frequently Asked Questions ›

Alnylam Assist® get started icon

See How to Get Started

Once you and your doctor decide to begin treatment with ONPATTRO, we'll work with your healthcare team to start the process.

How to Get Started

Alnylam Assist® Case Manager Natalie

Call Natalie

1-833-256-2748

Monday - Friday,
8am - 6pm

Alylam Separator Triangles

IMPORTANT SAFETY INFORMATION

What are the most important things I should know about ONPATTRO® (patisiran)?

ONPATTRO can cause:

• Infusion-related reactions

ONPATTRO is given as a drip into a vein (called an “intravenous infusion”). Reactions to this infusion may happen during treatment with ONPATTRO. Before each infusion you will be given medicines that help to lower the chance of infusion-related reactions.

Tell your doctor or nurse right away if you experience any of the following signs of an infusion-related reaction during treatment:

– Reddening of the face or body (flushing), skin warm
 – Body aches or pain, including pain in the back, neck, or joints
  – Feeling sick (nausea)
  – Stomach pain
  – Feeling short of breath, cough, or other breathing problems
  – Headache
  – Chest discomfort or chest pain
  – Rash
  – Chills
  – Dizziness
  – Feeling tired (fatigue)
  – Rapid heart rate
  – Facial swelling

If you have an infusion-related reaction, your doctor or nurse may slow down or stop your infusion, and you may need to take other medicines. When these reactions stop, or get better, your doctor or nurse may decide to start the infusion again.

• Low Vitamin A levels

Treatment with ONPATTRO lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking ONPATTRO, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of ONPATTRO?

The most common side effects of ONPATTRO are respiratory infections, such as colds, sinus infections, and nasal congestion, and infusion-related reactions. These are not all the possible side effects of ONPATTRO. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATION

What is ONPATTRO?

ONPATTRO is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). ONPATTRO is used in adults only.

For additional information about ONPATTRO, please see the full Prescribing Information.